New Drug Shows Promise for Myeloma Patients MSN Health & Fitness In younger people, the standard treatment is generally a stem cell transplant to replace the many of the cancerous plasma cells. However, many older patients are ineligible for this treatment. The first study looked at lenalidomide treatment in people ... New England Journal of Medicine Reports on Three Phase III REVLIMID ... |
